Session ID: 
BC3

The MediLedger Network:  Learnings from a (Real) Commercial Blockchain Network Running in the Pharmaceutical Industry

11:15am - 12:15pm Monday, March 9
Orlando - Orange County Convention Center
W307A
Additional Registration
Extra Fee

Description

Blockchain will transform the way companies exchange data and execute business processes between trading partners.  The MediLedger Project was started in 2017, bringing leading Pharma and Life Science companies together to better understand how blockchain powered solutions could enable compliance with the Drug Supply Chain Security Act (DSCSA).  The work has grown beyond pilot to live, commercial  decentralized solutions to verify drugs, and to also start looking at ROI opportunities in the revenue management processes associated with the sale of medicine.  This session will provide an overview of the work to date, potential impact of blockchain based solutions on how companies operate, and lessons learned along the way.
This session is part of a special program called Blockchain Symposium. Extra fees and separate registration is required.
This session is part of a special program called HIMSS20 Blockchain Symposium. Extra fees and separate registration is required.

Learning Objectives

  • Illustrate how Blockchain based solutions will change how companies do business with their trading partners
  • Describe live commercial applications of Blockchain based solutions running today
  • Summarize lessons learned that will guide companies in their decisions to participate in blockchain working groups going forward

Speaker(s)

CEO,
Chronicled

Continuing Education Credits

CAHIMS
1.00
CME
1.00
CNE
1.00
CPHIMS
1.00

Audience

CIO/CTO/CTIO/Senior IT
CISO/CSO
Investor/Entrepreneur

Level

Intermediate